Serves as a model for the development of other triazole antifungal agents.

Diflucan’s role in surgical prophylaxis is defined in specific high-risk guidelines.

Its generic availability has dramatically reduced treatment costs globally.

Diflucan serves as first-line for many non-severe Candida albicans infections.

Concomitant Diflucan and warfarin requires intense INR monitoring due to increased bleeding risk.

Diflucan is a valuable tool for treating susceptible Candida urinary tract infections.

Diflucan is ineffective against Fusarium and Scedosporium species.

Diflucan loading doses are used to achieve therapeutic levels rapidly in serious infections.

Its simplicity of use made it a cornerstone of early outpatient HIV management.

Diflucan can unmask or exacerbate cutaneous lupus erythematosus.